Insider Trades42 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 25, 2026 | Sell | NVST | Paul A Keel | Chief Executive Officer | 12,811 | $23.43 | $4.4B | -12.10% | +42.46% | $300.2K | -3.33% | — | — |
| Feb 25, 2026 | Sell | NVST | Stefan Nilsson | President, Nobel Biocare | 182 | $29.59 | $4.4B | -12.10% | +42.46% | $5.4K | -0.21% | — | — |
| Feb 25, 2026 | Sell | NVST | Veronica Acurio | President, Orthodontics | 1,412 | $29.59 | $4.4B | -12.10% | +42.46% | $41.8K | -1.72% | — | — |
| Feb 25, 2026 | Sell | NVST | Eric D. Hammes | Chief Financial Officer | 2,045 | $29.59 | $4.4B | -12.10% | +42.46% | $60.5K | -1.25% | — | — |
| Feb 25, 2026 | Sell | NVST | Robert Befidi | President, Diagnostics | 2,177 | $29.59 | $4.4B | -12.10% | +42.46% | $64.4K | -2.81% | — | — |
| Feb 25, 2026 | Sell | NVST | Mischa Reis | SVP, Strategy & Bus. Dev. | 2,976 | $29.59 | $4.4B | -12.10% | +42.46% | $88.1K | -5.21% | — | — |
| Feb 25, 2026 | Sell | NVST | Mark E Nance | General Counsel | 3,368 | $29.59 | $4.4B | -12.10% | +42.46% | $99.7K | -2.69% | — | — |
| Feb 25, 2026 | Sell | NVST | Faez C Kaabi | Chief Accounting Officer | 4,964 | $29.59 | $4.4B | -12.10% | +42.46% | $146.9K | -9.93% | — | — |
| Feb 25, 2026 | Sell | NVST | Paul A Keel | Chief Executive Officer | 11,840 | $29.59 | $4.4B | -12.10% | +42.46% | $350.3K | -1.99% | — | — |
| Feb 10, 2026 | Sell | NVST | Mischa Reis | SVP, Strategy & Bus. Dev. | 19,350 | $23.63 | $4.4B | -12.10% | +42.46% | $457.2K | +0.00% | 10b5-1 | — |
| Nov 1, 2025 | Sell | NVST | Paul A Keel | Chief Executive Officer | 54,097 | $20.35 | $4.4B | -12.10% | +42.46% | $1.1M | -13.47% | — | — |
| Aug 25, 2025 | Sell | NVST | Stefan Nilsson | President, Nobel Biocare | 804 | $21.12 | $4.4B | -12.10% | +42.46% | $17.0K | -1.44% | — | — |
| Aug 25, 2025 | Sell | NVST | Robert Befidi | President, Diagnostics | 3,454 | $21.12 | $4.4B | -12.10% | +42.46% | $72.9K | -7.06% | — | — |
| Aug 25, 2025 | Sell | NVST | Veronica Acurio | President, Orthodontics | 5,422 | $21.12 | $4.4B | -12.10% | +42.46% | $114.5K | -9.73% | — | — |
| Aug 25, 2025 | Sell | NVST | Eric D. Hammes | Chief Financial Officer | 7,654 | $21.12 | $4.4B | -12.10% | +42.46% | $161.7K | -7.33% | — | — |
| Aug 25, 2025 | Sell | NVST | Mischa Reis | SVP, Strategy & Bus. Dev. | 15,000 | $21.60 | $4.4B | -12.10% | +42.46% | $324.0K | -31.66% | 10b5-1 | — |
| May 25, 2025 | Sell | NVST | Paul A Keel | Chief Executive Officer | 12,787 | $16.72 | $4.4B | -12.10% | +42.46% | $213.8K | -3.09% | — | — |
| Feb 25, 2025 | Sell | NVST | Robert Befidi | President, Diagnostics | 1,123 | $20.66 | $4.4B | -12.10% | +42.46% | $23.2K | -1.36% | — | — |
| Feb 25, 2025 | Sell | NVST | Mark E Nance | General Counsel | 3,691 | $20.66 | $4.4B | -12.10% | +42.46% | $76.3K | -2.77% | — | — |
| Feb 25, 2025 | Sell | NVST | Mischa Reis | SVP, Strategy & Bus. Dev. | 3,813 | $20.66 | $4.4B | -12.10% | +42.46% | $78.8K | -4.88% | — | — |
| Feb 25, 2025 | Sell | NVST | Faez C Kaabi | Chief Accounting Officer | 4,319 | $20.66 | $4.4B | -12.10% | +42.46% | $89.2K | -6.42% | — | — |
| Nov 1, 2024 | Sell | NVST | Paul A Keel | Chief Executive Officer | 53,996 | $20.94 | $4.4B | -12.10% | +42.46% | $1.1M | -13.41% | — | — |
| Sep 17, 2024 | Sell | NVST | Mischa Reis | SVP, Strategy & Bus. Dev. | 812 | $19.00 | $4.4B | -12.10% | +42.46% | $15.4K | -1.87% | — | — |
| Aug 25, 2024 | Sell | NVST | Robert Befidi | President, Diagnostics | 3,454 | $18.70 | $4.4B | -12.10% | +42.46% | $64.6K | -3.04% | — | — |
| Aug 13, 2024 | Buy | NVST | Paul A Keel | Chief Executive Officer | 30,000 | $16.87 | $4.4B | -12.10% | +42.46% | $506.1K | +8.05% | — | — |
| Aug 12, 2024 | Buy | NVST | Eric D. Hammes | Chief Financial Officer | 24,532 | $16.33 | $4.4B | -12.10% | +42.46% | $400.6K | — | — | — |
| Jul 15, 2024 | Sell | NVST | Mark E Nance | General Counsel | 491 | $15.94 | $4.4B | -12.10% | +42.46% | $7.8K | -0.85% | — | — |
| May 25, 2024 | Sell | NVST | Eric Conley | SVP, Orthodontics | 642 | $18.25 | $4.4B | -12.10% | +42.46% | $11.7K | -1.19% | — | — |
| Feb 25, 2024 | Sell | NVST | Eric Conley | SVP, Orthodontics | 1,241 | $22.65 | $4.4B | -12.10% | +42.46% | $28.1K | -1.56% | — | — |
| Feb 25, 2024 | Sell | NVST | Faez C Kaabi | Chief Accounting Officer | 1,505 | $22.65 | $4.4B | -12.10% | +42.46% | $34.1K | -4.20% | — | — |
| Feb 25, 2024 | Sell | NVST | Stephen Keller | Principal Financial Officer | 1,562 | $22.65 | $4.4B | -12.10% | +42.46% | $35.4K | -5.47% | — | — |
| Feb 25, 2024 | Sell | NVST | Mark E Nance | General Counsel | 2,600 | $22.65 | $4.4B | -12.10% | +42.46% | $58.9K | -2.83% | — | — |
| Feb 25, 2024 | Sell | NVST | Mischa Reis | SVP, Strategy & Bus. Dev. | 4,134 | $22.65 | $4.4B | -12.10% | +42.46% | $93.6K | -6.53% | — | — |
| Feb 25, 2024 | Sell | NVST | Amir Aghdaei | Chief Executive Officer | 33,367 | $22.65 | $4.4B | -12.10% | +42.46% | $755.8K | -6.15% | — | — |
| Nov 16, 2023 | Buy | NVST | Eric Conley | SVP, Orthodontics | 2,185 | $22.89 | $4.4B | -12.10% | +42.46% | $50.0K | +1.56% | — | — |
| Nov 8, 2023 | Buy | NVST | Mark E Nance | General Counsel | 5,000 | $21.75 | $4.4B | -12.10% | +42.46% | $108.8K | +14.69% | — | — |
| Nov 6, 2023 | Buy | NVST | Stephen Keller | Principal Financial Officer | 2,000 | $21.53 | $4.4B | -12.10% | +42.46% | $43.1K | +18.07% | — | — |
| Nov 6, 2023 | Buy | NVST | Amir Aghdaei | Chief Executive Officer | 10,000 | $21.53 | $4.4B | -12.10% | +42.46% | $215.3K | +0.86% | — | — |
| Sep 17, 2023 | Sell | NVST | Mischa Reis | SVP, Strategy & Bus. Dev. | 787 | $28.87 | $4.4B | -12.10% | +42.46% | $22.7K | -2.47% | — | — |
| Sep 17, 2023 | Sell | NVST | Patrik Eriksson | Senior Vice President | 1,298 | $28.87 | $4.4B | -12.10% | +42.46% | $37.5K | -1.60% | — | — |
| Sep 17, 2023 | Sell | NVST | Howard H Yu | Chief Financial Officer | 1,965 | $28.87 | $4.4B | -12.10% | +42.46% | $56.7K | -4.28% | — | — |
| Sep 17, 2023 | Sell | NVST | Amir Aghdaei | Chief Executive Officer | 18,394 | $28.87 | $4.4B | -12.10% | +42.46% | $531.0K | -6.06% | — | — |